Both in Biotechnology
Champions Oncology vs Cognition Therapeutics
Over the past year CSBR returned −28.6% and CGTX returned −56.5%; their daily moves had a correlation of 0.07.
CSBR −28.6% CGTX −56.5%Growth of $1, one year, split-adjusted
| Metric | CSBR | CGTX |
|---|---|---|
| Price | $4.83 | $0.6833 |
| Market cap | $67.2M | $65.0M |
| Today | 0.00% | −2.32% |
| 1 month | −3.6% | −27.3% |
| 6 months | −19.2% | −44.4% |
| Year to date | −30.1% | −49.4% |
| 1 year | — | −58.3% |
| Revenue growth (YoY) | +8.8% | — |
| Gross margin | 50.5% | — |
| Net margin | −2.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.1× | — |
| Net cash | $4.4M | $34.0M |
| Dividend yield | — | — |
| Volatility (60d) | 34.9% | 47.7% |
| Short % of float | 1.5% | 8.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).